UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 385

Sortiert nach

Current use of PSMA-PET in prostate cancer management

Nature reviews. Urology, 2016-04, Vol.13 (4), p.226

2016

Link zum Volltext

Verfügbarkeit prüfen

Salvage-Lymphadenektomie beim Prostatakarzinom

Urologe. Ausgabe A, 2024-03, Vol.63 (3), p.234-240

2024

Link zum Volltext

Verfügbarkeit prüfen

Immuntherapie in der Uroonkologie: Checklisten, Therapiepläne und Patienteninformationen

1, 2021

Link zum Volltext

Verfügbarkeit prüfen

Neue Tracer und Kombinationen bei der Radioligandentherapie des Prostatakarzinoms

Die Urologie, 2023-07, Vol.62 (7), p.691-695

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

The Journal of urology, 2016-05, Vol.195 (5), p.1436

2016

Link zum Volltext

Verfügbarkeit prüfen

Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany

PloS one, 2016-11, Vol.11 (11), p.e0165801-e0165801

2016

Link zum Volltext

Verfügbarkeit prüfen

Algorithmus Blasenkarzinom

Der Onkologe, 2018, Vol.24 (1), p.5-5

Gschwend, Jürgen E.

2018

Link zum Volltext

Verfügbarkeit prüfen

Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy

The Journal of nuclear medicine (1978), 2016-11, Vol.57 (11), p.1713-1719

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma

Clinical cancer research, 2013-03, Vol.19 (5), p.1257-1268

2013

Link zum Volltext

Verfügbarkeit prüfen

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

BMC cancer, 2017-05, Vol.17 (1), p.361-361, Article 361

2017

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study

Journal of clinical oncology, 2014-05, Vol.32 (14), p.1412-1418

2014

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer

European urology, 2015-09, Vol.68 (3), p.530-534

2015

Link zum Volltext

Verfügbarkeit prüfen

Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer

The Journal of urology, 2016-08, Vol.196 (2), p.382

2016

Link zum Volltext

Verfügbarkeit prüfen

AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide

European urology, 2017-11, Vol.72 (5), p.828-834

2017

Link zum Volltext

Verfügbarkeit prüfen

Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer

European urology, 2019-10, Vol.76 (4), p.517-523

2019

Link zum Volltext

Verfügbarkeit prüfen

Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up

BJU international, 2017-07, Vol.120 (1), p.40-47

2017

Link zum Volltext

Verfügbarkeit prüfen

Behandlungsalgorithmen bei Hodentumoren

Der Onkologe, 2017-02, Vol.23 (2), p.87-88

Gschwend, Jürgen E.

2017

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer

European urology, 2009-04, Vol.55 (4), p.826-835

2009

Link zum Volltext

Verfügbarkeit prüfen

Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases

BMC cancer, 2020-06, Vol.20 (1), p.536-9, Article 536

2020

Link zum Volltext

Verfügbarkeit prüfen

Fear of cancer recurrence and disease progression in long‐term prostate cancer survivors after radical prostatectomy: A longitudinal study

Cancer, 2021-11, Vol.127 (22), p.4287-4295

2021

Link zum Volltext

Verfügbarkeit prüfen

The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score

European urology, 2018-07, Vol.74 (1), p.17-23

2018

Link zum Volltext

Verfügbarkeit prüfen

Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography

European urology, 2022-08, Vol.82 (2), p.156-160

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 385

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(323)
Mit Volltextzugriff
(341)

Publikationsform

Artikel
(360)
Buchkapitel
(17)
Bücher
(7)
Berichte
(1)

Sprache

Englisch
(288)
Deutsch
(94)
Japanisch
(27)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Current use of PSMA-PET in prostate cancer management

Salvage-Lymphadenektomie beim Prostatakarzinom

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

Immuntherapie in der Uroonkologie: Checklisten, Therapiepläne und Patienteninformationen

Neue Tracer und Kombinationen bei der Radioligandentherapie des Prostatakarzinoms

Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany

Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial

Algorithmus Blasenkarzinom

Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy

Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study

Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer

Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer

AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide

Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer

Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up

Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study

Behandlungsalgorithmen bei Hodentumoren

The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer

Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases

Fear of cancer recurrence and disease progression in long‐term prostate cancer survivors after radical prostatectomy: A longitudinal study

The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score

Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography

Suchergebnisse filtern